![](/img/cover-not-exists.png)
Evaluating lanreotide as maintenance therapy after first-line treatment in patients with non-resectable duodeno-pancreatic neuroendocrine tumours
Lepage, Côme, Dahan, Laetitia, Bouarioua, Nadia, Toumpanakis, Christos, Legoux, Jean-Louis, Le Malicot, Karine, Guimbaud, Rosine, Smith, Denis, Tougeron, David, Lievre, Astrid, Cadiot, Guillaume, Di FVolume:
49
Language:
english
Journal:
Digestive and Liver Disease
DOI:
10.1016/j.dld.2017.02.004
Date:
May, 2017
File:
PDF, 375 KB
english, 2017